Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis

Background: Convalescent plasma (CCP) has been used for treating some infectious diseases; however, the efficacy of CCP in coronavirus disease 2019 (COVID-19) remains controversial. The aim of this research was to assess the efficacy of CCP as an adjunctive treatment in COVID-19 patients. Methods: E...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardhani, Shinta Oktya, Fajar, Jonny Karunia, Wulandari, Laksmi, Soegiarto, Gatot, Purnamasari, Yeni, Asmiragani, Anisa, Maliga, Helnida Anggun, Ilmawan, Muhammad, Seran, Gloriana, Iskandar, Dheka Sapti, Ndapa, Conchita Emiliana, Hamat, Viviana, Wahyuni, Rafika Ajeng, Cyntia, Linda Oktaviana Suci, Maarang, Feronika Maryanti, Beo, Yosef Andrian, Adar, Olivera Agnes, Rakhmadhan, Iraky Mardya, Shantikaratri, Emilia Tiara, Putri, Ayu Sekarani Damana, Wahdini, Rizqa, Broto, Endang Pati, Suwanto, Agnes Wanda, Tamara, Fredo, Mahendra, Aditya Indra, Winoto, Eden Suryoiman, Krisna, Pratista Adi, Harapan, Harapan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182694/
https://www.ncbi.nlm.nih.gov/pubmed/34136130
http://dx.doi.org/10.12688/f1000research.36396.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182694/
https://www.ncbi.nlm.nih.gov/pubmed/34136130
http://dx.doi.org/10.12688/f1000research.36396.3

Ejemplares similares